Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

177.66
Delayed Data
As of Jun 26
 -2.49 / -1.38%
Today’s Change
145.37
Today|||52-Week Range
195.81
+7.21%
Year-to-Date
Biotech Stock Roundup: Vertex, AMAG Drugs Get FDA Nod, Conatus Study Fails & More
Jun 26 / Zacks.comZAK - Paid Partner Content
Vertex Pharmaceuticals Inc (VRTX) CEO & President Jeffrey M Leiden Sold $9.8 million ...
Jun 20 / GuruFocus NewsGURU - Paid Partner Content
The 10 Biggest Biotech Stocks
Jun 25 / MotleyFool.comFOO - Paid Partner Content
Top Stock Reports for Deere, Las Vegas Sands & Vertex
Jun 19 / Zacks.comZAK - Paid Partner Content
3 Big Biotechs Hold Growth Potential in Second Half of 2019
Jun 21 / Zacks.comZAK - Paid Partner Content
3 Cheap Drug Stocks You Can Buy Right Now
Jun 16 / MotleyFool.comFOO - Paid Partner Content

Today’s Trading

Previous close180.15
Today’s open180.11
Day’s range177.13 - 181.03
Volume768,712
Average volume (3 months)1,261,345
Market cap$47.1B
Data as of 4:15pm ET, 06/26/2019

Growth & Valuation

Earnings growth (last year)+677.36%
Earnings growth (this year)+6.51%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+22.51%
P/E ratio21.4
Price/Sales14.09
Price/Book10.58

Competitors

 Today’s
change
Today’s
% change
AGNAllergan+1.57+0.97%
ZTSZoetis Inc-0.81-0.71%
TAKTakeda Pharmaceutica...+0.10+0.57%
REGNRegeneron Pharmaceut...-7.82-2.50%
Data as of 4:15pm ET, 06/26/2019

Financials

Next reporting dateJuly 24, 2019
EPS forecast (this quarter)$1.08
Annual revenue (last year)$3.0B
Annual profit (last year)$2.1B
Net profit margin68.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
Chief Financial Officer &
Executive Vice President
Charles F. Wagner
Corporate headquarters
Boston, Massachusetts

Forecasts